Comparison

A-366833 European Partner

Manufacturer TargetMol
Category
Type Inhibitor
Specific against other
Amount 5mg
Item no. TMO-T29509-5mg
CASRN 370882-41-0
eClass 6.1 30220300
eClass 9.0 32160605
Available
Short Description
A-366833 is a novel nicotinic acetylcholine receptor (NACHR) ligand developed by Abbott that binds to the agonist binding site ([3H]-cytisine) with a Ki value of 3.1 nM and shows agonist selectivity for alpha4beta2 NACHR.
Shipping
cool pack
Storage
-20°
Target names or alias
A366833
Molecular Weight
200, 24

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close